Endy, a 51-year-old professor of bioengineering at Stanford University, is a star in the emerging field of synthetic biology. But in the search for the proverbial next big thing over the next 20 years, synthetic biology is a prime candidate. “For the first time ever, synthetic biology companies are on the verge of making money instead of consuming money,” he said. He’ll hold up a smartphone and say that in not so many years it can be made with synthetic biology. The International Genetically Engineered Machine Foundation, or iGEM, runs annual contests for teams of students making synthetic biology projects, from kits of biobricks.

Source: bd News24 November 29, 2021 13:17 UTC